Skip to main content

Table 1 Clinical characteristics of the two groups

From: Efficacy of concurrent chemoradiotherapy plus Endostar compared with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study

 

CCRT + E group

(n = 43)

CCRT group

(n = 45)

P value

Average age (range)

44.7 years (27–64)

43.6 years (24–66)

0.515

Sex

   

 Men

29 (67.4%)

32 (71.1%)

0.709

 Women

14 (32.6%)

13 (28.9%)

Clinical stage (7th,UICC/AJCC)

  

0.955

 III

16 (37.2%)

15 (33.3%)

 IVa

22 (51.2%)

24 (53.3%)

 IVb

5 (11.6%)

6 (13.3%)

T stage

  

0.609

 T1

0 (0)

0 (0)

 T2

2 (4.7%)

5 (11.1%)

 T3

16 (37.2%)

15 (33.3%)

 T4

25 (58.1%)

25 (55.6%)

N stage

  

0.312

 N0

0 (0)

0 (0)

 N1

21 (48.8%)

28 (62.2%)

 N2

17 (39.5%)

11 (24.4%)

 N3

5 (11.6%)

6 (13.3%)

  1. CCRT, concurrent chemoradiotherapy; E, Endostar; T, primary tumor; N, regional lymph nodes